Received Jun 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | E13499 | IM / LA |
Site: Swelling at Injection Site-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Additional Details: Pt notified the pharmacy that she had swelling, itching, and rash occur around the injection site the next day. Pt states that ever since getting the first covid shot a couple years ago, she has developed allergies and sensitivities to unknown allergens. pt had not informed the pharmacist at the time of imz and just agreed to receive the Tdap as recommended. Pt has been taking oral antihistamin to help with the symptoms & stated will reach out to primary care for further management as necessary